COVID-19 Burden in Hospitals Affects Risk for In-Hospital Adverse Events
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 7, 2024 -- Greater hospital COVID-19 burden is associated with an increased risk for in-hospital adverse events (AEs) among patients with and without COVID-19 in the United States, according to a study published online Nov. 4 in JAMA Network Open.
Mark L. Metersky, M.D., from the University of Connecticut School of Medicine in Farmington, and colleagues examined whether hospital COVID-19 burden was associated with the rate of in-hospital AEs in a cohort study including 40,737 Medicare hospital admissions (4,114 patients with COVID-19 and 36,623 without).
The researchers found there were 59.1, 77.0, and 97.4 AEs per 1,000 admissions during weeks with the lowest, intermediate, and highest COVID-19 burden, respectively. There were 55.7, 74.0, and 79.3 AEs per 1,000 admissions during weeks with the lowest, intermediate, and highest COVID-19 burden among patients without COVID-19. Patients with COVID-19 had a similar pattern. For all patients, the relative risk for AEs among those admitted during weeks with high versus low COVID-19 burden was 1.23 after risk adjustment, with similar results among those with and without COVID-19.
"These results illustrate the need for greater resilience, including systems of care that promote patient safety and planning for surge capacity in hospitals to prevent declines in patient safety and effectiveness of care during increases in demand, such as from pandemics, natural disasters, or other causes," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-08 06:00
Read more
- Depression Rates on the Rise for Sexual, Gender Minority College Students
- FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea
- Icotrokinra Delivered an Industry-Leading Combination of Significant Skin Clearance with Demonstrated Tolerability in a Once Daily Pill in Phase 3 Topline Results
- Get With The Guidelines-Stroke Participation Has Improved Stroke Care
- Primary Care Encounter Notes Often Lack Thoroughness
- Flu-Linked Hospitalization Rates Vary Across Seasons, Highest in Adults 65+
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions